Richard Stewart
Overview
Richard Stewart received an average of $955K in total compensation, including $414K in salary, at OncoGenex Pharmaceuticals from 2017 to 2022.
2022OncoGenex PharmaceuticalsExecutive Chairman
2021OncoGenex PharmaceuticalsExecutive Chairman
2020OncoGenex PharmaceuticalsExecutive Chairman and Former Chief Executive Officer
2019OncoGenex PharmaceuticalsChairman and Chief Executive Officer
2018OncoGenex PharmaceuticalsChairman and Chief Executive Officer
2017OncoGenex PharmaceuticalsChairman and Chief Executive Officer
Source: SEC filings on April 28, 2023, April 21, 2022, March 30, 2021, April 2, 2020, March 28, 2019, and April 19, 2018.
Related executives
We found 11 more executives who work or worked at OncoGenex Pharmaceuticals.
John Bencich
OncoGenex Pharmaceuticals
Chief Executive Officer
Cindy Jacobs
OncoGenex Pharmaceuticals
Chief Medical Officer
Anthony Clarke
OncoGenex Pharmaceuticals
Chief Scientific Officer
Scott Cormack
OncoGenex Pharmaceuticals
Chief Executive Officer
Michelle Burris
OncoGenex Pharmaceuticals
Chief Financial Officer
Susan Wyrick
OncoGenex Pharmaceuticals
Principal Accounting Officer and Vice President, Finance
Stephen Anderson
OncoGenex Pharmaceuticals
Chief Financial Officer
Cameron Lawrence
OncoGenex Pharmaceuticals
Principal Accounting Officer
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019